http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14163006

Outgoing Links

Predicate Object
contentType Comparative Study|Journal Article
endingPage 198
issn 0046-8177
pageRange 187-198
publicationName Human Pathology
startingPage 187
bibliographicCitation Meguro S, Akamatsu T, Matsushima S, Kosugi I, Kawasaki H, Arai Y, Baba S, Tsuchida T, Shido Y, Suda T, Iwashita T. Phenotypic characterization of perivascular myoid cell neoplasms, using myosin 1B, a newly identified human pericyte marker. Hum Pathol. 2017 Apr;62():187–98. doi: 10.1016/j.humpath.2016.12.024. PMID: 28088345.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3456034c316b2a1a42e6a74d7477b36d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c28609a598acfbf1c1c705df7643f5fe
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4909-3933
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4170-7005
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f4c0e2e111d67b6f3a59aa8c2b60b281
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4a96c627873450380cd16401259f4345
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_61f6f145f857340e6148083e8b6b6d68
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5b7a564ca758ec93cb382415ce6fa4cf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_09fcf8aa8952474e504279dbcce1c6c9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc3b30b291100a2a435fccb608327644
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c9895e4181572c840c1dc5a5a4087920
date 201704
identifier https://doi.org/10.1016/j.humpath.2016.12.024
https://pubmed.ncbi.nlm.nih.gov/28088345
isPartOf https://portal.issn.org/resource/ISSN/0046-8177
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4136
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Phenotypic characterization of perivascular myoid cell neoplasms, using myosin 1B, a newly identified human pericyte marker
discusses http://id.nlm.nih.gov/mesh/M0014366
http://id.nlm.nih.gov/mesh/M0003217
http://id.nlm.nih.gov/mesh/M0022149
http://id.nlm.nih.gov/mesh/M000601764
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D047708Q000737
http://id.nlm.nih.gov/mesh/D012983Q000737
http://id.nlm.nih.gov/mesh/D014408Q000032
http://id.nlm.nih.gov/mesh/D024461Q000032
http://id.nlm.nih.gov/mesh/D018229Q000737
http://id.nlm.nih.gov/mesh/D005918Q000737
http://id.nlm.nih.gov/mesh/D020286Q000737
hasSubjectTerm http://id.nlm.nih.gov/mesh/D012983Q000235
http://id.nlm.nih.gov/mesh/D020286Q000473
http://id.nlm.nih.gov/mesh/D019070
http://id.nlm.nih.gov/mesh/D047708Q000235
http://id.nlm.nih.gov/mesh/D012983Q000473
http://id.nlm.nih.gov/mesh/D012867Q000737
http://id.nlm.nih.gov/mesh/D032389Q000473
http://id.nlm.nih.gov/mesh/D005455
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D008810
http://id.nlm.nih.gov/mesh/D047708Q000473
http://id.nlm.nih.gov/mesh/D002454
http://id.nlm.nih.gov/mesh/D005918Q000235
http://id.nlm.nih.gov/mesh/D018229Q000235
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D020869
http://id.nlm.nih.gov/mesh/D010641
http://id.nlm.nih.gov/mesh/D014408Q000235
http://id.nlm.nih.gov/mesh/D002148Q000032
http://id.nlm.nih.gov/mesh/D008822
http://id.nlm.nih.gov/mesh/D032389Q000737
http://id.nlm.nih.gov/mesh/D005918Q000473
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D005347Q000737
http://id.nlm.nih.gov/mesh/D024461Q000235
http://id.nlm.nih.gov/mesh/D018229Q000473
http://id.nlm.nih.gov/mesh/D001706
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D000368
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10150
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6666
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID712
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d61f1652fd3fdf3b798c2da9992aad4b
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68245
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7841

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4430

Total number of triples: 77.